Eli Lilly and Company
LLY 1216.95 (0.21%) 2.56
Health Care
Pharmaceuticals
Quality Checklist 6/8
5Y Shares Out Change < 0%
ROIC > 10%
Current Ratio > 1
Net Margin > 10%
Past Net Income CAGR > 0%
Est. EPS Growth > 5%
Debt/Equity < 1
Quick Ratio > 1
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $1.09(T)
EV: $1.25(T)
Total Equity: $31.20(B)
Earnings date: Aug-05-2026
P/E: 43.15
Forward P/E: 33.60
P/FCF: 91.98
P/S: 15.10
P/B: 34.85
EPS: $28.2
EPS (fwd): $36.2
FCF/share: $13.2
Revenue/share: $80.6
Book value/share: $34.9
ROIC: 32.9%
ROA: 19.3%
ROE: 96.8%
Debt/Equity: 1.39
Current Ratio: 1.50
Gross margin: 82.8%
Operating margin: 45.1%
Net margin: 35.0%
Dividend/share: $6.2
Div. yield: 0.51%
TTM Financials
Income (TTM)
Revenue$72.25(B)
Gross profit$59.84(B)
EBITDA$36.22(B)
Net income$25.28(B)
Gross margin82.8%
Operating margin45.1%
Net margin35.0%
Shares outstanding891.74(M)
Balance sheet
Total assets$116.58(B)
Current assets$54.84(B)
Total liabilities$85.38(B)
Current liabilities$36.63(B)
Cash & Short-term inv.$5.28(B)
Long-term debt$39.37(B)
Total intangibles$13.50(B)
PP&E$26.54(B)
Cash flow (TTM)
FCF$11.82(B)
CapEx$-8.66(B)
Dividends paid$-5.59(B)
Stock issued$0
Stock repurchased$-5.26(B)
Stock-based comp.$633.00(M)
Debt issued$8.48(B)
Debt repaid$-4.02(B)